Fulcrum Therapeutics
FULC
FULC
170 hedge funds and large institutions have $762M invested in Fulcrum Therapeutics in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 43 increasing their positions, 48 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
25.1% more ownership
Funds ownership: 99.44% → 124.55% (+25%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 48
Holders
170
Holding in Top 10
2
Calls
$8.87M
Puts
$2.69M
Top Buyers
| 1 | +$28.9M | |
| 2 | +$24.4M | |
| 3 | +$19.8M | |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
+$19.3M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$12M |
Top Sellers
| 1 | -$42.5M | |
| 2 | -$10.1M | |
| 3 | -$7.45M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.89M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$3.84M |
